FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Adalimumab-adaz Injection
Status: Discontinuation
»Therapeutic Categories: Rheumatology

Expand all

Sandoz Inc. (New 01/13/2026)

Company Contact Information:
800-525-8747

Presentation	Posting Date	Related Information
Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-20)	04/14/2025	Equivalent Sandoz format is available.
Hyrimoz, Injection, 20 mg/.2 mL (NDC 61314-476-64)	04/14/2025	Equivalent Sandoz format is available.
Hyrimoz, Injection, 10 mg/.1 mL (NDC 61314-509-64)	04/14/2025	Equivalent Sandoz format is available.
Hyrimoz, Injection, Kit (NDC 61314-531-64)	01/13/2026	Equivalent Sandoz format is available.
Hyrimoz, Injection, Kit (NDC 61314-517-36)	01/13/2026	Equivalent Sandoz format is available.
Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)	01/13/2026	Equivalent Sandoz format is available.
Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)	01/13/2026	Equivalent Sandoz format is available.
Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)	01/13/2026	Equivalent Sandoz format is available.